Navigation Links
Biopsy Device Market (By Country Wise and Product Segment) and Biopsy Procedure Volume Forecast To 2020 - Global Analysis
Date:4/12/2017

NEW YORK, April 12, 2017 /PRNewswire/ -- Biopsy devices are gaining traction within the industry as a viable alternative to traditional screening methods for cancer. The biopsy device market will experience considerable growth over the forecast period, driven by an increasing number of biopsy procedures. An increasing prevalence of cancer, geriatric population and increasing demand for minimally invasive procedures are expected to drive market growth during the forecast period. Growing patient awareness levels and the advancement in biopsy techniques are also expected to fuel future growth of the market.

By Product Segment - Biopsy Device Market Analysis: The market for biopsy guidance systems held the largest share in 2015 and is expected to continue to lead the market throughout the forecasting period. The biopsy guidance systems is followed by the needle based biopsy guns segment. Vacuum-assisted biopsy devices represent the fastest growing segment, and increased Medicare reimbursement given for such procedures is expected to help fuel demand. The market for biopsy needles is expected to remain relatively constant throughout the forecasting period. Forceps and Other devices are expected to account for lesser shares as compared to the other segments, due to their specific applications and also risks associated with their use.

By Country Biopsy Device Market Analysis: United States is the largest regional market for biopsy devices. United States is likely to remain the leading country in biopsy device market throughout the forecasting period. China is the second leading market for biopsy devices being followed by India. Brazil is the fourth most popular country for biopsy devices accounting for XXXX% market share in 2015. Among the European countries, Germany is the leading market for Biopsy device accounting for XXXX% market share in 2015.

By Region Biopsy Procedure Volume Analysis: In the Global biopsy procedure volume, Asia accounted for the largest share in 2015. It is predicted that Asia will remain at the dominating position in Global biopsy procedures throughout the forecasting period. United States holds the second largest volume share in 2015. Europe is the third leading region for biopsy procedure being followed by Brazil.

Company Wise Biopsy Products Analysis: In this segment company wise detailed analysis of biopsy products have been covered along with features and advantages of biopsy products. The report also studies major mergers and acquisition/deals in the biopsy market landscape.

This is the 2nd edition report on Biopsy Market by iGATE RESEARCH. The report titled "Biopsy Device Market (By Country Wise and Product Segment) and Biopsy Procedure Volume Forecast To 2020 - Global Analysis" is a 233 Page report with 61 Figures and 9 Tables. This report studies in detail the Global Biopsy Device Market, Biopsy Procedure Volume, Products Segment Market for Biopsy Devices, Country Wise Biopsy Device Market and Biopsy Procedure Volume, Companies Biopsy Products Analysis, Major deals in Biopsy Device Market, Driving Factors and Challenges for Biopsy Device Market.

Biopsy Device Market and Forecast - 5 Biopsy Device Segments Covered

1. Needle-based Biopsy Guns (2012 - 2020)
2. Biopsy Needles (2012 - 2020)
3. Biopsy Forceps (2012 - 2020)
4. Biopsy Guidance Systems (2012 - 2020)
5. Others (2012 - 2020)

Biopsy Device Market and Forecast - 11 Countries Covered

1. United States (2012 - 2020)
2. Brazil (2012 - 2020)
3. UK (2012 - 2020)
4. France (2012 - 2020)
5. Germany (2012 - 2020)
6. Italy (2012 - 2020)
7. Spain (2012 - 2020)
8. Japan (2012 - 2020)
9. India (2012 - 2020)
10. China (2012 - 2020)
11. Rest of the World (2012 - 2020)

Companies Biopsy Products Analysis - 11 Companies Covered

1. Argon Medical Devices
2. Boston Scientific
3. Carefusion Corporation (Acquired By Becton, Dickinson and Company)
4. C. R. BARD, Inc
5. Cook Medical
6. Devicor Medical Products Inc.
7. Gallini Medical Devices
8. Hologic, Inc
9. INRAD, Inc
10. Intact Medical Corporation
11. TSK Laboratory

Biopsy Procedure Volume and Forecast - 4 Regions Covered

1. United States (2012 - 2020)
2. Asia (2012 - 2020)
3. Europe (2012 - 2020)
4. Brazil (2012 - 2020)

Research Methodologies

Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases

Read the full report: http://www.reportlinker.com/p04603838-summary/view-report.html

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com


__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/biopsy-device-market-by-country-wise-and-product-segment-and-biopsy-procedure-volume-forecast-to-2020---global-analysis-300439048.html


'/>"/>
SOURCE Reportlinker
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. QIAGEN Expands Liquid Biopsy Pipeline with AR-V7 Test in Prostate Cancer
2. Indivumed Founder and CEO Recognized for Contribution to Liquid Biopsy Innovation
3. QIAGEN Joins CANCER-ID Consortium for Liquid Biopsy Workflows
4. Biocept and Catalyst Pharmaceuticals Collaborate to Provide Liquid Biopsy Testing for Small Cell Lung Cancer to Patients with Lambert Eaton Myasthenic Syndrome (LEMS)
5. MD Anderson and Guardant Health announce partnership to make comprehensive liquid biopsy part of oncology standard of care
6. Microfabrica Partners with US Endoscopy to Produce Worlds First Submillimeter Biopsy Forceps
7. Global Liquid Biopsy Market Forecast 2017-2027
8. Guardant Health to create a new 500-plus-gene liquid biopsy panel with several leading pharmaceutical companies to accelerate clinical trials and drug development
9. MDNA Selects Phi Life Sciences as its First US Distribution Partner for its New Liquid Biopsy Test for Prostate Cancer
10. DILON Diagnostics and GE Healthcare announce the FDA clearance of the Discovery NM 750b biopsy accessory
11. QIAGEN Launches Liquid Biopsy Workflow for GeneReader NGS System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2017)... Fix Inc. (" Fortuna "), a private, clinical-stage biotech ... need for embryonic and fetal stem cells by using direct ... Fortuna announced today the launch of its Scientific ... PhD; Father Kevin FitzGerald , S.J., PhD; Col. (R) ... Giordano , PhD. "We are excited and honored ...
(Date:5/4/2017)... , May 4, 2017  DarioHealth Corp. (NASDAQ: ... health and big data solutions, today announced that it ... Company, and STI Technologies Limited to lower diabetes healthcare ... Through STI,s innoviCares card, which is available throughout all ... DarioHealth customers will be eligible for additional savings when ...
(Date:5/3/2017)... ROCKVILLE, Md. , May 3, 2017 /PRNewswire/ ... revenue growth of nine percent next year and ... solid organ and hematopoietic stem cell (HSCT) or ... and donor. Molecular testing technologies are well-suited for this ... healthcare-only market research publisher Kalorama Information. The various ...
Breaking Medicine Technology:
(Date:5/23/2017)... ... ... Axiad IDS , a leading provider of trusted identities for enterprise, ... a “Top 25 Cybersecurity Companies 2017.” Axiad IDS received this honor in ... address potential cybersecurity threats before they happen. The annual list of top ...
(Date:5/23/2017)... (PRWEB) , ... May 23, 2017 , ... ... the pharmaceutical and medical device sectors, today announced the winners of its 3rd ... Entrepreneurs) represent the most influential people in the healthcare industry today. , Out ...
(Date:5/23/2017)... ... May 23, 2017 , ... New England Journal Of Medicine Confirms Viability of ... Response”, -The Rory Staunton Foundation Calls on Health & Human Services, Tom Price to ... ( http://www.rorystauntonfoundation.org ) today reported on a new study released on May 21, 2017 ...
(Date:5/23/2017)... ... May 23, 2017 , ... The National ... is pleased to announce the organization’s Certified Strength Coach credential has earned accreditation ... Coach (CSC) program validates the competency of qualified candidates for jobs in the ...
(Date:5/23/2017)... ... May 23, 2017 , ... ... Reconstructive Surgeon Dr. Kevin Sadati, is pleased to announce a new treatment option ... and elastin in their face, neck, and body through a virtually pain-free, non-surgical ...
Breaking Medicine News(10 mins):